Akiko Iwasaki, PhD has received monetary support for CynAxis, an immunological approach to provide drug access to the central nervous system (CNS). The vast majority of drugs and biologics fail to enter the brain for treatment of brain cancers and neurological diseases. Iwasaki’s discovery has yielded key insights into how the immune system naturally overcomes the blood brain barrier to fight infections. She intends to leverage this knowledge to enable safe and transient drug access to the CNS using a simple intranasal peptide delivery approach.
For the complete story and list of receipients, visit: OCR News